Kaplan E Sadock Pdf
Download Kaplan E Sadock Pdf PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Kaplan E Sadock Pdf book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages.
Comprehensive Review of Psychiatry
Author: Rajesh R. Tampi
language: en
Publisher: Lippincott Williams & Wilkins
Release Date: 2008
Derived from a popular review course for residents and fellows at Yale University's Department of Psychiatry, this comprehensive question-and-answer review book will prepare resident and practicing psychiatrists for all types of standardized examinations, including the PRITE, the American Board of Psychiatry and Neurology written exam, and recertification exams. The book contains 2,000 multiple-choice questions divided into ten 200-question tests, and each test covers all psychiatry and neurology topics in the ABPN curriculum. An answer section with complete answers, explanations, and references for further review follows each test. All of the questions will be available on a companion Website, so that readers can take the tests online. (www.comprehensivereviewofpsychiatry.com)
Evidence synthesis and meta-analysis
Author: Council for International Organizations of Medical Sciences (CIOMS)
language: en
Publisher: Council for International Organizations of Medical Sciences
Release Date: 2016-12-30
At any point in the drug development process, systematic reviews and meta-analysis can provide important information to guide the future path of the development programme and any actions that might be needed in the post-marketing setting. This report gives the rationale for why and when a meta-analysis should be considered, all in the context of regulatory decision-making, and the tasks, data collection, and analyses that need to be carried out to inform those decisions. There is increasing demand by decision-makers in health care, the biopharmaceutical industry, and society at large to have access to the best available evidence on benefits and risks of medicinal products. The best strategy will take an overview of all the evidence and where it is possible and sensible, combine the evidence and summarize the results. For efficacy, the outcomes generally use the same or very similar predefined events for each of the trials to be included. Most regulatory guidance and many Cochrane Collaboration reviews have usually given more attention to assessment of benefits, while issues around combining evidence on harms have not been as well-covered. However, the (inevitably) unplanned nature of the data on safety makes the process more difficult. Combining evidence on adverse events (AEs), where these were not the focus of the original studies, is more challenging than combining evidence on pre-specified benefits. This focus on AEs represents the main contribution of the current CIOMS X report. The goal of the CIOMS X report is to provide principles on appropriate application of meta-analysis in assessing safety of pharmaceutical products to inform regulatory decision-making. This report is about meta-analysis in this narrow area, but the present report should also provide conceptually helpful points to consider for a wider range of applications, such as vaccines, medical devices, veterinary medicines or even products that are combinations of medicinal products and medical devices. Although some of the content of this report describes highly technical statistical concepts and methods (in particular Chapter 4), the ambition of the working group has been to make it comprehensible to non-statisticians for its use in clinical epidemiology and regulatory science. To that end, Chapters 3 and 4, which contain the main technical statistical aspects of the appropriate design, analysis and reporting of a meta-analysis of safety data are followed by Chapter 5 with a thought process for evaluating the findings of a meta-analysis and how to communicate these. https://doi.org/10.56759/lela7055
Psychiatry Board Review
Author: Dr. Rajesh Tampi
language: en
Publisher: Oxford University Press
Release Date: 2017-03-29
The field of psychiatry is evolving rapidly specifically in the areas of classification of many psychiatric disorders, psychopharmacology and psychotherapeutics. The new Diagnostic and Statistical Manual of Mental Disorders: DSM-5 which was introduced in 2013 forms the basis of the new classification system in psychiatry. The American Board of Psychiatry and Neurology is also in the process of phasing in DSM-5 criteria to the board examination, such that by 2017 the examination material will exclusively reflect the new manual. As psychiatric trainees and psychiatrists prepare for their certification and recertification examinations using the new classification system, a new board review textbook is imperative to address these changes in order to prepare them for the certification examinations as well as for their clinical practice. To help with this process we have compiled a list of 1000 questions and answers in psychiatry and neurology using the most current information available in the field and using the DSM 5 classification system. This book has been specifically written for the busy professional who does not have the time to access numerous resources necessary to prepare for professional examinations.